Clinical Trial Update: A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC) [Phase 1]

View source ↗

Summary

A Phase 1 study of LIV001 in healthy subjects and patients with Ulcerative Colitis has completed, sponsored by Liveome Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LIV001

Snippet

Sponsor: Liveome Inc. | Conditions: Ulcerative Colitis | Phase 1 | Status: COMPLETED